187 related articles for article (PubMed ID: 22061617)
1. Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor.
Burrel S; Aït-Arkoub Z; Agut H; Boutolleau D
Antiviral Res; 2012 Jan; 93(1):199-203. PubMed ID: 22061617
[TBL] [Abstract][Full Text] [Related]
2. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
Burrel S; Deback C; Agut H; Boutolleau D
Antimicrob Agents Chemother; 2010 Nov; 54(11):4833-42. PubMed ID: 20733037
[TBL] [Abstract][Full Text] [Related]
3. Nuclear import of HSV-1 DNA polymerase processivity factor UL42 is mediated by a C-terminally located bipartite nuclear localization signal.
Alvisi G; Avanzi S; Musiani D; Camozzi D; Leoni V; Ly-Huynh JD; Ripalti A
Biochemistry; 2008 Dec; 47(52):13764-77. PubMed ID: 19053255
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
5. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
[TBL] [Abstract][Full Text] [Related]
6. The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region.
Loregian A; Piaia E; Cancellotti E; Papini E; Marsden HS; Palù G
Virology; 2000 Jul; 273(1):139-48. PubMed ID: 10891416
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus.
Bohn K; Zell R; Schacke M; Wutzler P; Sauerbrei A
Antivir Ther; 2011; 16(7):989-97. PubMed ID: 22024514
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
[TBL] [Abstract][Full Text] [Related]
9. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
10. Effects of substitutions of arginine residues on the basic surface of herpes simplex virus UL42 support a role for DNA binding in processive DNA synthesis.
Randell JC; Komazin G; Jiang C; Hwang CB; Coen DM
J Virol; 2005 Sep; 79(18):12025-34. PubMed ID: 16140778
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
Sauerbrei A; Deinhardt S; Zell R; Wutzler P
Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
[TBL] [Abstract][Full Text] [Related]
12. Interaction of herpes simplex virus type 1 DNA polymerase and the UL42 accessory protein with a model primer template.
Gottlieb J; Challberg MD
J Virol; 1994 Aug; 68(8):4937-45. PubMed ID: 8035492
[TBL] [Abstract][Full Text] [Related]
13. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal third of UL42, a HSV-1 DNA replication protein, is dispensable for viral growth.
Gao M; DiTusa SF; Cordingley MG
Virology; 1993 Jun; 194(2):647-53. PubMed ID: 8389077
[TBL] [Abstract][Full Text] [Related]
15. The essential in vivo function of the herpes simplex virus UL42 protein correlates with its ability to stimulate the viral DNA polymerase in vitro.
Reddig PJ; Grinstead LA; Monahan SJ; Johnson PA; Parris DS
Virology; 1994 May; 200(2):447-56. PubMed ID: 8178434
[TBL] [Abstract][Full Text] [Related]
16. Identification of a small molecule that inhibits herpes simplex virus DNA Polymerase subunit interactions and viral replication.
Pilger BD; Cui C; Coen DM
Chem Biol; 2004 May; 11(5):647-54. PubMed ID: 15157875
[TBL] [Abstract][Full Text] [Related]
17. Analysis of in vitro activities of herpes simplex virus type 1 UL42 mutant proteins: correlation with in vivo function.
Thornton KE; Chaudhuri M; Monahan SJ; Grinstead LA; Parris DS
Virology; 2000 Sep; 275(2):373-90. PubMed ID: 10998337
[TBL] [Abstract][Full Text] [Related]
18. The processivity factor complex of feline herpes virus-1 is a new drug target.
Zhukovskaya NL; Guan H; Saw YL; Nuth M; Ricciardi RP
Antiviral Res; 2015 Mar; 115():17-20. PubMed ID: 25542973
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase.
Zuccola HJ; Filman DJ; Coen DM; Hogle JM
Mol Cell; 2000 Feb; 5(2):267-78. PubMed ID: 10882068
[TBL] [Abstract][Full Text] [Related]
20. Sequences at the C-terminus of the herpes simplex virus type 1 UL30 protein are dispensable for DNA polymerase activity but not for viral origin-dependent DNA replication.
Stow ND
Nucleic Acids Res; 1993 Jan; 21(1):87-92. PubMed ID: 8382792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
